InvestorsHub Logo
Followers 56
Posts 14300
Boards Moderated 0
Alias Born 01/19/2009

Re: frrol post# 144749

Friday, 09/18/2020 2:43:02 PM

Friday, September 18, 2020 2:43:02 PM

Post# of 146210
This is false:

Diwan is clearly 100% focused on a CV therapy now.



All we know is that Diwan has recently made two contradictory claims: 1) that he is focused on a shingles ointment, and NOT trying to commercialize a covid indication, and 2) that he has "nominated" a covid candidate to move towards clinical trials.

Which one to believe? Based on his previous 15-year history of making dozens of claims that all turned out to be false, neither?

To remind you of the former:


"Despite the press releases and media appearances on coronavirus, Diwan said the company is focused on a different disease.

Our priority remains our lead drug candidate for the treatment of shingles rash. ... We have limited resources that we must judiciously prioritize towards making our drug development programs successful,” he said in that email. “We are performing activities for the coronavirus project solely from a humanitarian perspective.”


Vyas confirmed by email in late April that this remained correct. The company has not responded to CNBC’s follow-up questions.
"
https://www.cnbc.com/2020/07/14/biopharma-nanoviricides-sees-stock-soar-on-coronavirus-claims.html

A casual stroll through the lunatic asylum shows that faith does not prove anything. Friedrich Nietzsche

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News